USD 0.02
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -2.39 Million CAD | -32.58% |
2022 | -555.42 Thousand CAD | 68.02% |
2021 | -1.73 Million CAD | -1312.13% |
2020 | 143.28 Thousand CAD | -30.47% |
2019 | 206.07 Thousand USD | 1083.2% |
2018 | -20.96 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 352.24 Thousand CAD | 457.51% |
2024 Q1 | -187.5 Thousand CAD | -9.96% |
2023 Q2 | -223.47 Thousand USD | -71.15% |
2023 Q1 | -130.57 Thousand CAD | -818.03% |
2023 FY | -736.37 Thousand CAD | -32.58% |
2023 Q4 | -170.52 Thousand CAD | -11.6% |
2023 Q3 | -152.8 Thousand USD | 31.62% |
2022 Q3 | -120.3 Thousand CAD | -4.68% |
2022 Q2 | -114.92 Thousand CAD | 36.7% |
2022 Q1 | -181.54 Thousand CAD | 46.94% |
2022 FY | -555.42 Thousand CAD | 68.02% |
2022 Q4 | -14.22 Thousand CAD | 88.18% |
2021 Q2 | -481.49 Thousand CAD | 14.12% |
2021 Q3 | -358.11 Thousand CAD | 25.62% |
2021 Q4 | -342.12 Thousand CAD | 4.46% |
2021 FY | -1.73 Million CAD | -1312.13% |
2021 Q1 | -560.63 Thousand CAD | -1001.04% |
2020 FY | 143.28 Thousand CAD | -30.47% |
2020 Q4 | -50.91 Thousand CAD | -184.83% |
2020 Q3 | 60.02 Thousand CAD | 221.9% |
2020 Q2 | 18.64 Thousand CAD | -72.9% |
2020 Q1 | 68.81 Thousand CAD | 742.87% |
2019 Q2 | 146.98 Thousand CAD | 132.28% |
2019 Q4 | -10.7 Thousand CAD | -111.07% |
2019 Q1 | 63.27 Thousand CAD | 0.0% |
2019 Q3 | 96.68 Thousand CAD | -34.22% |
2019 FY | 206.07 Thousand USD | 1083.2% |
2018 FY | -20.96 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Bio Medica Corporation | -1.24 Million USD | -93.19% |
Arrayit Corporation | -3.62 Million USD | 33.764% |
Atlantic International Corp. | -5.73 Million USD | 58.144% |
Biocept, Inc. | -31.98 Million USD | 92.498% |
Bioqual, Inc. | -19.63 Thousand USD | -12118.271% |
CardioGenics Holdings Inc | -772.14 Thousand USD | -210.749% |
DermTech, Inc. | -103.73 Million USD | 97.687% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.096% |
HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 88.481% |
iMD Companies, Inc. | -175.44 Thousand USD | -1267.614% |
IDenta Corp. | -1499.00 USD | -159968.312% |
Interpace Biosciences, Inc. | 2.8 Million USD | 185.571% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | 6301.665% |
InVitro International | -25.33 Thousand USD | -9369.292% |
Lumos Diagnostics Holdings Limited | -7.12 Million USD | 66.31% |
Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -4028.965% |
Medical Imaging Corp. | -819.48 Thousand USD | -192.798% |
NovelStem International Corp. | -3.52 Million USD | 31.947% |
Optigenex Inc. | 1.39 Million USD | 272.517% |
PharmChem, Inc. | 973.14 Thousand USD | 346.563% |
Proteome Sciences plc | -1.62 Million USD | -48.021% |
Response Genetics, Inc | -21.37 Million USD | 88.776% |
Rennova Health, Inc. | -1.4 Million USD | -70.228% |
RushNet, Inc. | -684.7 Thousand USD | -250.432% |
ScreenPro Security Inc. | -2.59 Million USD | 7.445% |
Stella Diagnostics Inc. | -11.42 Million USD | 79.002% |
StageZero Life Sciences Ltd. | -7.74 Million USD | 69.027% |
Todos Medical Ltd. | -9.74 Million USD | 75.385% |